This study, called the PROMISE Trial, is looking at different ways to help people manage lymphedema and fibrosis in their head and neck after cancer treatment. It compares two self-management programs (LEF-SMP), one in-person and one through telehealth, against usual care. The goal is to see if these programs can improve how you manage your lymphedema and fibrosis, reduce symptoms, help with daily activities, and improve your quality of life. You might be able to join if you are over 18, have finished your head and neck cancer treatment, have no signs of cancer, and have head and neck lymphedema with or without fibrosis. The study will measure changes in the severity of your lymphedema and fibrosis over 9 months to see if the programs are successful. The current status of this study is unclear.

Study design

This interventional study plans to enroll 204 participants. It compares three groups: in-person LEF-SMP, telehealth LEF-SMP, and usual care.

What's involved

Participants will engage in self-care activities prescribed by therapists or receive one of the LEF-SMP interventions. Measurements will be taken at the start, then at 3, 6, and 9 months after the intervention.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 9 months after their intervention to assess changes in lymphedema and fibrosis severity.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.